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RESEARCH ARTICLE
Klf5 maintains the balance of primitive endoderm versus epiblast
specification during mouse embryonic development by
suppression of Fgf4
Takuya Azami1,2, Tsuyoshi Waku3, Ken Matsumoto1, Hyojung Jeon2, Masafumi Muratani4,
Akihiro Kawashima2, Jun Yanagisawa5,6, Ichiro Manabe7, Ryozo Nagai8, Tilo Kunath9,
Tomonori Nakamura10,11, Kazuki Kurimoto10,11, Mitinori Saitou10,11,12,13, Satoru Takahashi2,6,14 and
Masatsugu Ema1,15,*
ABSTRACT
The inner cell mass of the mouse blastocyst gives rise to the
pluripotent epiblast (EPI), which forms the embryo proper, and the
primitive endoderm (PrE), which forms extra-embryonic yolk sac
tissues. All inner cells coexpress lineage markers such asNanog and
Gata6 at embryonic day (E) 3.25, and the EPI and PrE precursor cells
eventually segregate to exclusively express Nanog and Gata6,
respectively. Fibroblast growth factor (FGF)–extracellular signal-
regulated kinase (ERK) signalling is involved in segregation of the
EPI and PrE lineages; however, the mechanism involved in Fgf4
regulation is poorly understood. Here, we identified Klf5 as an
upstream repressor of Fgf4. Fgf4 was markedly upregulated in Klf5
knockout (KO) embryos at E3.0, and was downregulated in embryos
overexpressing Klf5. Furthermore, Klf5 KO and overexpressing
blastocysts showed skewed lineage specification phenotypes,
similar to FGF4-treated preimplantation embryos and Fgf4 KO
embryos, respectively. Inhibitors of the FGF receptor (Fgfr) and
ERK pathways reversed the skewed lineage specification of Klf5 KO
blastocysts. These data demonstrate that Klf5 suppresses Fgf4-Fgfr-
ERK signalling, thus preventing precocious activation of the PrE
specification programme.
KEY WORDS: Inner cell mass, Primitive endoderm, Epiblast, Fgf4,
Klf5, Mouse
INTRODUCTION
Mammalian preimplantation embryo development segregates into
three fundamental cell lineages. The first lineage segregation event
separates an epithelial cell layer called the trophectoderm (TE) on
the surface of the embryo, which gives rise to trophoblast tissues of
the placenta, and the inner cell mass (ICM), which gives rise to the
embryo proper and extra-embryonic mesoderm. The second lineage
segregation event further differentiates the ICM into epiblast (EPI)
cells and the primitive endoderm (PrE). EPI cells generate most of
the embryo proper and are a source of pluripotent embryonic stem
cells (ESCs), whereas the PrE generates visceral and parietal
endoderm tissues, and these become the visceral and parietal yolk
sacs (Rossant and Tam, 2009). After compaction, inner cells
generated in the first wave of cell division (8- to 16-cell stage)
mainly contribute to EPI cells, whereas inner cells generated in the
second wave (16- to 32-cell stage) are biased towards PrE cells
(Morris et al., 2010). However, a previous study did not observe
such predetermination in EPI and PrE specification (Yamanaka
et al., 2010).
Single-cell analysis revealed that inner cells at embryonic day (E)
3.25 randomly coexpress EPI and PrE markers and eventually
acquire either an EPI or a PrE identity (Guo et al., 2010; Kurimoto
et al., 2006; Ohnishi et al., 2014). The mechanism involved in the
emergence and specification of EPI and PrE precursor cells is not
fully understood (Bedzhov and Zernicka-Goetz, 2015; Hermitte and
Chazaud, 2014). The cell fate of EPI and PrE precursors is still
plastic at E3.75 and is fully committed to EPI and PrE cells at
∼E4.0-4.25 (Grabarek et al., 2012; Nichols et al., 2009; Yamanaka
et al., 2010).
Nanog and Gata6 mRNAs are detectable as early as the 2-cell
stage (Guo et al., 2010), and both Nanog and Gata6 proteins are
coexpressed in all inner cells at E3.25 (∼32 cells) (Dietrich and
Hiiragi, 2007; Plusa et al., 2008). Variability in the initial Nanog
expression level shows no correlation with that of Gata6 in
individual inner cells at E3.25 (Ohnishi et al., 2014). As embryos
develop, the salt-and-pepper distributions of Nanog and Gata6 are
evident in ICM cells until E3.5-4.0 (Chazaud et al., 2006; Plusa
et al., 2008). The establishment of this salt-and-pepper distribution
of Nanog and Gata6 is poorly understood; however, fibroblast
growth factor (FGF)–extracellular signal-regulated kinase (ERK)Received 22 February 2017; Accepted 25 August 2017
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signalling is postulated to play key roles (Chazaud et al., 2006; Kang
et al., 2013; Krawchuk et al., 2013; Nichols et al., 2009; Ohnishi
et al., 2014; Yamanaka et al., 2010). Fgf4-Fgfr-ERK signalling
determines the balance of the EPI and PrE cell lineages:
overactivation of FGF signalling caused by exogenous FGF4
converts all ICM cells to PrE cells (Yamanaka et al., 2010), whereas
all ICM cells acquire EPI identity when FGF signalling is blocked
by small chemical inhibitors of Fgfr and ERK (Nichols et al., 2009),
by gene knockout (KO) of Fgf4 (Kang et al., 2013; Krawchuk et al.,
2013), and by KO of the expression of the adapter molecule Grb2
(Chazaud et al., 2006). Fgf4 KO embryos show normal Nanog and
Gata6 expression levels at E3.25; thus, the initial coexpression of
Nanog and Gata6 is independent of Fgf4 (Kang et al., 2013;
Krawchuk et al., 2013; Ohnishi et al., 2014). Subsequently, the
segregation of EPI and PrE precursor cells is believed to be
mediated by reciprocal repression between Nanog and Gata6 (Singh
et al., 2007). In agreement with this model, the loss of Gata6 results
in a complete shift into the EPI lineage, while there is no effect on
the Nanog expression level at E3.0-3.25; thus, the initial expression
of Nanog is independent of Gata6 at E3.0-3.25 (Bessonnard et al.,
2014; Schrode et al., 2014). Importantly, single-cell analysis
showed that bimodal Fgf4 expression precedes asymmetric Nanog
and Gata6 expression and is the first sign of the segregation of the
EPI and PrE lineages (Guo et al., 2010; Ohnishi et al., 2014).
Currently, what regulates Fgf4 at this developmental stage is
unknown (Artus and Chazaud, 2014; Chazaud and Yamanaka,
2016).
Klf5, a member of the Krüppel-like factor (Klf ) family of
transcription factors, functions in the maintenance of pluripotency
and in somatic cell reprogramming (Takahashi and Yamanaka,
2006). Klf5 marks a naïve state of human pluripotent stem cells
(Chan et al., 2013; Theunissen et al., 2014). Target gene inactivation
of Klf5 causes failure of TE and ICM development (Ema et al.,
2008; Lin et al., 2010), but the molecular mechanism underlying
Klf5-regulated ICM development is not well understood.
Here, we show that the inner cells of Klf5 KO embryos adopt a
PrE lineage fate at the expense of EPI cells, while Klf5-
overexpressing (OE) embryos show incomplete lineage
segregation as indicated by the persistence of Nanog+/Gata6+
double-positive cells. We show that Fgf4 expression is upregulated
in Klf5 KO embryos at E3.0, whereas Fgf4 is repressed in Klf5 OE
blastocysts. Importantly, single-cell analysis clearly demonstrates
that Fgf4 is derepressed in a subset of Fgf4-high inner cells of Klf5
KO embryos. Chromatin immunoprecipitation (ChIP) assays
indicate that the Fgf4 locus is occupied by Klf5, suggesting direct
regulation of Fgf4 by Klf5. In terms of the emergence of Nanog+
pluripotent EPI cells, the phenotypes of Klf5 KO embryos can be
reversed by either Fgfr or ERK inhibition. Taken together, these
results provide new insights into the interplay between Klf5 and the
Fgf4-Fgfr-ERK pathway crucial for the proper lineage segregation.
RESULTS
Skewed EPI and PrE lineage specification in Klf5 KO and OE
blastocysts
Although Klf5 is indispensable for blastocyst development, the
mechanistic functions of Klf5 in ICM development and early
lineage segregation remain elusive (Ema et al., 2008; Lin et al.,
2010). In a previous study, the Klf5-lacZ allele (Ema et al., 2008)
was generated by inserting a lacZ cassette into the second exon of
Klf5, leaving the rest of the Klf5 locus with the potential to generate
a C-terminally truncated protein of ∼164 amino acids in length
(Fig. S1A). To delete almost the entire open reading frame of Klf5,
we generated a new KO mouse for Klf5 that removes the two major
coding exons (designated Klf5Δ2nd3rd exon) (Fig. S1B). Similar to
Klf5-lacZmice (Fig. S1A) (Ema et al., 2008), no homozygous pups
were obtained from heterozygous intercrosses of the Klf5Δ2nd3rd
exon mice, and homozygous Klf5Δ2nd3rd exon/Δ2nd3rd exon embryos
showed implantation defects (Fig. S1C). When Klf5 KO morulae
(Klf5lacZ/lacZ orKlf5Δ2nd3rd exon/Δ2nd3rd exon) at E2.5 were stained with
antibodies against lineage markers such as Oct3/4 (Pou5f1) and
Cdx2, both types of Klf5 KO embryos showed decreased levels of
Cdx2 and normal levels of Oct3/4 protein expression (Fig. S1D,E).
Hereafter, theKlf5Δ2nd3rd exon allele was used as the null allele for
our study.
To obtain insight into the role of Klf5 in early embryogenesis, we
established a new ESC line with Cre-mediated overexpression of the
FLAG/HA-Klf5 cassette (Fig. S1F). We used the ESC line, which
expresses GFP prior to Cre-mediated excision, to generate the
conditional Klf5 OE mice (Fig. S1G). Upon crossing to the Ayu1-
Cre driver line, we confirmed that Klf5 protein is overexpressed
1.5-fold in Klf5 OE blastocysts compared with wild type (WT)
(Fig. S1H).
First, we collected embryos carefully timed every 6 h from E3.25
onwards and found that Klf5 KO embryos had fewer cells than their
WT counterparts (Fig. S1I). The total cell number per Klf5 KO
embryo never exceeded 64 until E4.25 (Fig. S1I; data not shown).
Given that bromodeoxyuridine (BrdU) incorporation was severely
affected, it is likely that cell cycle progression had been disturbed
(Fig. S1J,K). Co-staining embryos from E3.25 to E3.5 for BrdU
incorporation and terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labelling (TUNEL) showed that the cells defective
in BrdU incorporation were TUNEL+, suggesting that defective cell
cycle progression was promoting apoptosis (Fig. S1L).
Examination of Nanog and Gata6 expression levels in Klf5 KO
embryos revealed that the initial Nanog and Gata6 expression at
E3.25 was, overall, similar to that of WT embryos (Fig. 1A).
Analyses of Klf5 KO blastocysts at E3.5 and E3.75 showed that
most, if not all, ICM cells were Gata6+ and that few cells were
Nanog+ (Fig. 1A,C, Fig. S2A,C). Consistent with this result, Nanog
protein expression levels decreased in Klf5 KO embryos during
development from E3.25 to E4.0, whereas Gata6 protein levels
increased (Fig. 1B). Since it was reported that Nanog+/Gata6+
double-positive (DP) common precursors differentiate
progressively into a Nanog+/Gata6− (Nanog+) EPI or Nanog−/
Gata6+ (Gata6+) PrE fate in an asynchronous manner (Saiz et al.,
2016), we evaluated the percentage of DP cells, Nanog+ cells and
Gata6+ cells from E3.25 to E4.0. The percentage of DP cells in Klf5
KO embryos decreased rapidly and, in turn, the percentage of
Gata6+ cells increased, indicating that bipotential DP cells in Klf5
KO embryos prefer to differentiate into Gata6+ PrE cells (Fig. 1C).
At the E4.0 late blastocyst stage, most cells in Klf5 KO embryos
acquired the Gata6+ PrE fate (Fig. 1A,C).
Our finding that only Gata6-expressing cells in Klf5 KO embryos
remain at E4.0 could be the consequence of apoptosis of Nanog+
EPI cells rather than of more cells differentiating into PrE. To gain
insight into the role of apoptosis in the EPI lineage, we analysed the
number of TUNEL+ cells in Klf5 KO and WT embryos at E3.5. We
found no significant changes in the percentage of Nanog+, Gata6+,
DP, or double-negative (DN) cells undergoing apoptosis between
WT and Klf5 KO embryos (Fig. S1M-O). This indicated that the
increase in the percentage of Gata6+ cells was not caused by the
death of any specific cell lineage, including EPI cells. Because the
percentage of DP cells inKlf5KO embryos was decreased (Fig. 1C),
DP cells were likely to have differentiated into PrE. Because the
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Klf5 KO embryos showed a cell proliferation defect (Fig. S1I) we
categorised embryos by similar total cell numbers (<32 or 32-64)
from various days of development and reached the same conclusion
(Fig. S2B-D).
When we investigated Nanog and Gata6 expression in Klf5 OE
embryos at E3.25, Klf5 OE blastocysts showed overall coexpression
of Nanog and Gata6 (Fig. 1A). The numbers of DP cells per embryo
at E3.5 to E4.0 were significantly increased in Klf5 OE embryos
(Fig. 1C, Fig. S2C,D). Whereas there were Gata6+ endoderm layers
and Nanog+ EPI cells in WT blastocysts at E4.5, there were still
significant numbers of DP cells centrally located towards presumably
uncommitted cells in Klf5 OE blastocysts at E4.5 (Fig. S2A,A′).
Accelerated PrE lineage specification in Klf5 KO embryos
Specification of the PrE lineage involves Gata6, followed by
sequential activation of Pdgfra, Sox17, Gata4 and Sox7 (Artus et al.,
2010, 2011; Kang et al., 2013; Plusa et al., 2008). Sox17 is activated
between the 32-cell and 64-cell stages (Artus et al., 2011; Morris
et al., 2010; Niakan et al., 2010); Gata4 expression marks the onset
of the mutual exclusion of Gata6 and Nanog and is activated at the
64-cell stage (Artus et al., 2011; Grabarek et al., 2012). Because we
observed a reduction in the percentage of Nanog+ cells and an
increase in Gata6+ cells in Klf5 KO embryos at E3.75, we tested
whether inner cells at E3.0 already exhibit signs of accelerated PrE
lineage specification. Immunohistochemistry did not show any
Fig. 1. Skewed EPI and PrE lineage specification in Klf5 KO and OE blastocysts. (A) Expression levels of Nanog and Gata6 in WT, Klf5 KO and Klf5
OE mouse embryos from E3.25-4.0. Confocal microscopy transverse sections are shown. Note that Nanog expression was reduced in Klf5 KO blastocysts
at E3.25 and was dramatically reduced after E3.5. Gata6 expression was induced at E3.25-E4.0. C, cell number. Scale bars: 20 µm. (B) Tukey box plots of
Nanog and Gata6 protein expression levels. Embryo numbers are shown in parentheses. A.U., arbitrary unit. The central mark is the median, the edges of the
box are the 25th and 75th percentiles, and the whiskers extend to 1.5× the interquartile range. (C) Percentage of Nanog+ (Nanog+/Gata6−), Gata6+
(Nanog−/Gata6+) and DP cells per embryo. *P<0.01, **P<0.001, versus WT (Mann–Whitney U-test). Embryo numbers are shown in parentheses.
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detectable Pdgfra or Sox17 protein expression in Klf5 KO morulae
at E3.0 (data not shown; Fig. S3A). However, at E3.25,
immunohistochemistry showed strong Pdgfra expression in most
of the inner cells of Klf5 KO embryos but not WT embryos
(Fig. 2A). Quantitation of Pdgfra+ cells indicated that over 80% of
the inner cells of Klf5 KO embryos were Pdgfra+, whereas fewer
than 20% of the inner cells of WT embryos were Pdgfra+ (Fig. 2B).
It is of note that a small increase in Pdgfra+ cells was observed in the
outer cells of Klf5 KO embryos (Fig. 2B). Taken together, the data
revealed that the inner cells of Klf5 KO embryos exhibit accelerated
PrE lineage specification as early as E3.25 (Fig. 2C).
We also found an increase in the percentage of Sox17+ cells in
Klf5 KO blastocysts at E3.5 (Fig. S3B-D), which was consistent
with a previous report (Lin et al., 2010). Furthermore, we found an
increase in the numbers of Gata4+ cells in Klf5 KO blastocysts at
E3.75, which was in sharp contrast with the small number of cells
found in Klf5 OE embryos (Fig. 2D,E). Gata4 protein expression
levels were increased in Klf5 KO embryos and decreased in Klf5
OE embryos (Fig. 2F). Collectively, these data indicated that Klf5
KO embryos show an accelerated PrE lineage specification in
the ICM.
During maturation of EPI cells at E4.25-4.5, it has been
demonstrated that downregulation of Nanog expression is a
hallmark of the naïve-to-primed transition of EPI cells (Kang
et al., 2017; Saiz et al., 2016; Smith, 2017). Elevated Nanog
expression in Klf5 OE embryos from E3.25 to E4.25 suggests that
these cells might remain in a naïve state and fail to differentiate into
mature EPI cells. To examine the consequence of ubiquitous
overexpression of Klf5, Klf5 OE embryos at E5.5 (egg cylinder
stage) were dissected and subjected to immunohistochemistry. In
WT embryos, Klf5 protein was expressed in extra-embryonic
ectoderm cells but not in EPI cells; however, Klf5 OE embryos still
expressed Klf5 protein in all cell lineages, including EPI cells
(Fig. S4). Thus, the elevated Nanog expression caused by Klf5 OE
did not block differentiation into EPI cells. Yamanaka and
colleagues indicated that even though Fgf4 heterozygous embryos
exhibit a reduction in the number of PrE cells, the embryos
eventually develop normally (Krawchuk et al., 2013). Thus,
although lower activity of the Fgf4-Fgfr-ERK pathway affects PrE
maturation it is restored during development. We presume that the
PrE maturation of Klf5 OE embryos is restored, as seen in Fgf4
heterozygous embryos. Klf5 OE embryos developed normally until
Fig. 2. Accelerated PrE lineage specification inKlf5KO embryos. (A) Upregulation of Pdgfra in the inner cells ofKlf5 KO embryos at E3.25. Note that the inner
cells of the Klf5 KO embryos were DP cells that strongly express Pdgfra. Arrowheads and arrow indicate inner cells and outer cells, respectively. Confocal
microscopy transverse sections at E3.25 are shown. C, cell number. (B) Absolute number of Pdgfra+ and Pdgfra− cells in inner or outer cells. (C) Illustration of
WT and Klf5 KO embryos at E3.25. More than 80% of inner cells in Klf5 KO embryos strongly expressed Pdgfra (indicated by the orange outline of the cell
membrane), but not in WTembryos, indicating accelerated PrE specification of the inner cells. (D) Expression of Nanog and Gata4 in WT and Klf5 KO blastocysts
fromE3.75. Gata4 expression levels were dramatically upregulated inKlf5KOblastocysts. Confocal microscopy transverse sections are shown. (E) Percentage of
Gata4+ cells per embryo. (F) Tukey box plots of Gata4 protein expression levels. Embryo numbers are shown in parentheses. A.U., arbitrary unit. *P<0.01,
**P<0.001 (Fig. 2B: Fisher’s exact test; Fig. 2E,F: Mann–Whitney U-test); n.s., not significant. Scale bars: 20 µm.
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E8.0 but then died at E11.5 for unknown reasons, while Klf5 KO
embryos showed reduced Cdx2 expression and failed to promote
blastocoel expansion, indicating a defect in TE development. Taken
together, these results indicated that loss or overexpression of Klf5
results in skewed cell fate specification in the EPI/PrE lineages
during preimplantation development.
Overactivation of the Fgf4-Fgfr-ERK pathway in Klf5 KO
embryos
To elucidate the molecular mechanism involved in the accelerated
PrE lineage specification of Klf5 KO embryos, microarray analyses
were performed using amplified cDNAs fromWTembryos andKlf5
KO embryos at E3.0 (Fig. S5A), which at this stage showed no
apparent defects and had normal expression levels of Oct3/4,
Nanog, Sox2 and Cdx2 mRNAs (Fig. S5B). Bioinformatic analysis
indicated that Fgf4 expression was upregulated inKlf5KO embryos,
whereas Spry4, a negative regulator of FGF-induced ERK
activation, was downregulated (Fig. 3A). Pdgfra and Sox17,
markers for the PrE lineage, were upregulated in Klf5 KO
embryos (Fig. 3A). In agreement with these observations,
quantitative reverse-transcription PCR (RT-qPCR) analysis
confirmed that Fgf4, Pdgfra and Sox17 were significantly
upregulated in Klf5 KO embryos at E3.0 (Fig. 3B). Quantification
of Sox17 immunostaining in Klf5 KO embryos showed increased
Fig. 3.Klf5 is required for the repression of Fgf4 expression inmorulae at E3.0. (A) Heat map summarizing expression data for representative genes involved
in Fgf4-ERK signalling and PrE specification. Colour intensity represents the mean-centered log2 expression; deeper red is associated with greater relative
gene expression, and deeper blue is associated with decreased relative gene expression. (B) Average of relative gene expression in Klf5 KO embryos compared
with WT embryos at E3.0. β-actin was used for the normalisation of mRNA expression. *P<0.05, **P<0.01 (Mann–Whitney U-test). (C) Increased expression
levels of FGF4 protein in Klf5 KO morulae at E3.0. Confocal transverse sections are shown. Insets are high-magnification images of FGF4+ cells. Data are
also shown for a negative control experiment on WT morulae without anti-FGF4 antibody (−Ab). C, cell number. (D) Tukey box plots showing FGF4 protein
expression levels in FGF4+ cells of WT and Klf5 KO morulae at E3.0. *P<0.01 (Mann–Whitney U-test). (E) FGF4 protein expression levels in FGF4+ cells of WT,
Klf5 KO and Klf5OE blastocysts at E3.25. Confocal transverse sections are shown. (F) Tukey box plots showing FGF4 protein expression levels in FGF4+ cells of
WT, Klf5 KO and Klf5 OE embryos at E3.25. *P<0.05, **P<0.01 (Mann–Whitney U-test). A.U., arbitrary unit. Scale bars: 20 µm.
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numbers of Sox17+ cells per embryo, as well as increased staining for
Sox17 on a per-cell level at E3.5 (Fig. S3C,D). Therefore, the
upregulation of PrE genes in the microarray analysis appears to reflect
a combination of increased PrE cells per embryo and, in some cases
such as Sox17, an increased level of PrE gene expression per cell.
To examine FGF4 protein expression in Klf5 KO embryos, we
validated an anti-FGF4 antibody by staining mouse Fgf4 KO and
WT ESCs and found that it could exclusively recognise endogenous
FGF4 protein expressed in these cells (Fig. S5C). We further
validated the anti-FGF4 antibody by staining the Nanog+ EPI cells
of WT blastocysts at E3.75 (Fig. S5D) and found that the staining
pattern was consistent with a previous report by Frankenberg et al.
(2011). Immunohistochemical analysis with this antibody
confirmed that FGF4 was abundantly expressed in Klf5 KO
embryos at E3.0 and E3.25 (Fig. 3C-F). By contrast, FGF4
expression was significantly reduced in Klf5 OE embryos at E3.25,
indicating that Klf5 suppresses Fgf4 (Fig. 3E,F). Since Fgf4
encodes a secreted protein, it is difficult to identify Fgf4-expressing
cells. To resolve this issue, we performed single-cell RT-qPCR
analysis with amplified cDNA prepared from individual
blastomeres of inner cells of WT, Klf5 KO and Klf5 OE embryos
at E3.25 using the single-cell mRNA 3-prime end sequencing (SC3-
seq) method (Nakamura et al., 2015) (Fig. 4A). There were two
populations: Fgf4-high inner cells and Fgf4-low/negative inner
cells. Given that Pdgfra, Fgfr2 and Sox17 are expressed in Fgf4-
low/negative inner cells but not in Fgf4-high inner cells, these
populations might represent PrE and EPI cells, respectively
(Fig. 4A). There was no significant difference in the expression
pattern of major lineage markers, such asNanog,Gata6,Oct3/4 and
Sox2, between WT, Klf5 KO and Klf5 OE embryos (Fig. 4A).
Importantly, the proportion of Fgf4-high inner cells to Fgf4-low/
negative inner cells was significantly increased in Klf5 KO embryos
at E3.25 (Fig. 4B,C). Interestingly, Fgf4 mRNA was significantly
upregulated in Fgf4-high inner cells of Klf5 KO embryos but
downregulated in Fgf4-high inner cells of Klf5 OE embryos, as
compared with those of WT embryos (Fig. 4B,D). These results
clearly demonstrated that Klf5 suppresses Fgf4 in Fgf4-high inner
cells at E3.0-3.25.
To investigate whether Klf5 directly regulates Fgf4, we surveyed
the genomic binding sites of Klf5 by examining public ChIP-seq
data and found that three candidate regions in Fgf4 loci were
occupied by Klf5 in mouse ESCs (Fig. 4E). To verify this result, we
established ESC lines that overexpressed epitope-tagged Klf5 and
confirmed that the tagged protein binds to the three regions of Fgf4
(Fig. 4F) and to the promoter and enhancer regions of Nanog (Jeon
et al., 2016). These data suggest that Klf5 represses Fgf4 through
direct regulation. Although inner cells at E3.25 express Fgfr2
homogeneously, Fgf4 was observed to be expressed at two distinct
levels, namely high and low, in populations of cells (Guo et al.,
2010; Kurimoto et al., 2006; Ohnishi et al., 2014). However, the
regulatory mechanism of Fgf4 at early stages, such as in the morula,
is unknown (Chazaud and Yamanaka, 2016). To the best of our
knowledge, we are the first to identify Klf5 as a crucial regulator of
Fgf4 at E3.0-3.25.
Of note, although cis-regulatory regions in the Fgf4 promoter and
enhancers are occupied by Klf5 (Fig. 4E,F), a lack of Klf5
expression did not significantly alter Fgf4 expression in mouse
ESCs (Fig. S5E). This finding suggests a minor role for Klf5 in the
transcription of Fgf4 in mouse ESCs, in contrast to its strongly
suppressive role on Fgf4 at E3.0 or E3.25. Previous work showed
that Klf5 is a context-dependent transcription factor and, depending
on the co-factor or nuclear environment, behaves as a transcriptional
repressor or activator on the same set of genes (Oishi et al., 2008).
Therefore, the different outcomes of Fgf4 transcription promoted by
the absence of Klf5 might result in a different cell type, i.e. inner
cells at E3.0-3.25 versus mouse ESCs (equivalent to EPI cells at
E4.25) (Boroviak et al., 2014).
Fgfr or MEK inhibitors reverse the skewed lineage
specification of Klf5 KO blastocysts
Our data indicate that Klf5 KO blastocysts show cell proliferation
defects and accelerated PrE specification (Fig. S1I, Figs 1 and 2),
yet it is not clear whether the overactivation of Fgf4-Fgfr-ERK
signalling is responsible for the cell proliferation defects and
accelerated PrE lineage specification in Klf5 KO embryos. In fact,
Lin et al. (2010) reported no difference in the phosphorylated ERK
(pERK) signal betweenWT and Klf5KO blastocysts. However, it is
of note that careful and extensive immunohistochemical analyses
showed that a strong background signal hampers the detection of
pERK in preimplantation embryos (Frankenberg et al., 2011),
whereas pERK signals can be observed reproducibly in whole
embryos after E5.5 (Corson et al., 2003).
To examine whether Fgf4-Fgfr-ERK signalling is responsible for
the phenotype of Klf5 KO blastocysts, we used chemical inhibitors
to block the kinase activities of Fgfr1/2 (SU5402) and MEK
(PD0325901) (Fig. 5A). Morulae at E2.75 were collected and
cultured for 24 h in the presence or absence of these inhibitors, and
we found that Klf5 KO embryos treated with either SU5402 or
PD0325901 showed marked phenotypic rescue in terms of a normal
morphology with an expanded blastocoel, indistinguishable from
WT blastocysts (Fig. 5B). The number of cells per embryo was also
increased but still significantly different from that of WT embryos,
suggesting that Klf5 regulates cell proliferation in part through an
Fgf4-Fgfr-ERK-independent mechanism (Fig. 5C). The number of
TUNEL+ cells was reduced dramatically in the inhibitor-treatedKlf5
KO embryos and was similar to that of WT embryos (Fig. 5C).
Notably, inhibitors of the JNK and p38 MAPK (Mapk14) pathways
did not significantly rescue the cell cycle defects of Klf5 KO
blastocysts (Fig. S6), indicating that JNK and p38 MAPK are not
involved in this process.
We also attempted to test whether excess FGF4 activity is
sufficient to cause defective cell proliferation in WT embryos and
found that culturing in the presence of FGF4 slightly increased the
number of TUNEL+ cells but did not significantly change total cell
number (Fig. 5D,E). When Klf5 OE embryos were cultured in the
presence of saturated levels of FGF4 (1 μg/ml) from E2.5 to E3.75
(Fig. S7A), this did not change total cell number (Fig. S7B-D);
however, Gata6 protein expression was significantly upregulated in
FGF4-stimulated Klf5 OE embryos (Fig. S7E).
To investigate whether the precocious activation of Fgf4-Fgfr-
ERK signalling was responsible for the altered lineage specification
of Klf5 KO blastocysts, WT and Klf5 KO morulae at E2.5 were
collected and cultured for 24 or 48 h in the presence or absence of
PD0325901 and were then subjected to immunohistochemistry
(Fig. 6A). Klf5 KO blastocysts cultured in vitro for 24 h from E2.5
showed reduced Nanog and increased Gata6 expression levels, as
did the Klf5 KO blastocysts at E3.5 (Fig. 6B,C). MEK inhibitor
treatment dramatically reversed the alterations in Nanog and Gata6
expression levels (Fig. 6B,C). When Klf5 KO morulae were treated
with PD0325901 from E2.5 for 24 h, most of the ICM cells were
Nanog+ EPI-biased cells (Fig. 6B,C). By contrast, when Klf5 KO
morulae were treated with vehicle alone for 24 h from E2.5, most of
the ICM cells were Gata6+ PrE cells. Importantly, the percentage of
Nanog+ cells among the ICM cells of Klf5 KO blastocysts cultured
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Fig. 4. See next page for legend.
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in the presence of PD0325901 was increased compared with WT,
but was still less than that of PD0325901-treated WT embryos
(Fig. 6C). When Klf5 KO morulae were treated with PD0325901
from E2.5 for 48 h (corresponding to E4.5), all the cells in the ICM
were Nanog+ EPI cells (Fig. 6B′).
Because our previous results indicated that ESC lines could not
be established from Klf5 KO blastocysts and that Klf5 was
indispensable for ESC derivation from the ICM (Ema et al.,
2008), we attempted to derive ESC lines from PD0325901-treated
Klf5 KO blastocysts. Sixty ESC lines were established and
genotyped. Seven Klf5 KO ESC lines were obtained (data not
shown), demonstrating that treatment with this MEK inhibitor
rescued the emergence of pluripotent EPI cells in Klf5 KO
blastocysts. By contrast, treatment with the MEK or Fgfr
inhibitors did not affect the reduced expression of Cdx2 (Fig. S8).
This suggested that the dysregulation of Cdx2 in Klf5 KO
blastocysts was not caused by increased signalling through the
Fgf4-Fgfr-ERK pathway but was nonetheless controlled by Klf5.
Taken together, our studies showed that the loss of Klf5 results in
the induction of Fgf4 in morula at E3.0, followed by the rapid
upregulation of Pdgfra in the inner cells at E3.25 and a decrease in
Nanog+ cells and DP cells at E3.5, which ultimately led to Gata6-
expressing cells only. This skewed EPI/PrE phenotype with Gata6-
only ICM cells was reversed by MEK inhibitors. However,
overexpression of Klf5 resulted in the reduction of Fgf4 in
blastocysts at E3.5 and an increase in Nanog+ cells and DP cells
at E3.5 or later, which ultimately led to the presence of DP
ʻuncommitted’ cells by E4.0. Therefore, our model is that Klf5
represses Fgf4-Fgfr-ERK signalling to suppress its precocious
activation of the PrE specification programme, thus ensuring the
emergence of Nanog+ naïve pluripotent cells during development
(Fig. 7).
DISCUSSION
Previous experiments showed that Nanog KO caused a severe
reduction in Fgf4 expression in blastocysts at E3.5, demonstrating
that Nanog activates Fgf4 expression in EPI precursor cells
(Frankenberg et al., 2011; Messerschmidt and Kemler, 2010).
Moreover, Oct3/4 KO led to reduced Fgf4 expression in blastocysts
at E3.5 (Frum et al., 2013; Le Bin et al., 2014). Furthermore, mutant
embryos lacking Sox2, which cooperates with Oct3/4 in the
maintenance of ESC pluripotency, showed reduced Fgf4 expression
(Wicklow et al., 2014). Because Oct3/4-Sox2 complexes can
directly induce Fgf4 expression in vitro (Ambrosetti et al., 2000),
there is an interplay between Nanog, Oct3/4 and Sox2 to regulate
Fgf4 for proper lineage segregation (Chazaud and Yamanaka,
2016). Thus, these studies showed that Nanog and Oct3/4 activate
Fgf4 expression in EPI precursor cells at the E3.5 blastocyst
stage; however, these studies did not address the regulatory
mechanism of Fgf4 at an earlier stage, such as the morula.
The mechanism involved in the induction of Fgf4 expression in a
subset of inner cells at this stage is still unknown (Chazaud and
Yamanaka, 2016). Our study demonstrated for the first time that
Klf5 is a crucial regulator for Fgf4 in the morula at E3.0, before the
blastocyst stage.
Bimodal Fgf4 expression levels precede the exclusive production
of Nanog and Gata6 (Guo et al., 2010; Ohnishi et al., 2014) and is
the first sign of the segregation of the EPI and PrE lineages.
However, what regulates Fgf4 is unknown (Artus and Chazaud,
2014; Chazaud and Yamanaka, 2016). Yamanaka and colleagues
clearly demonstrated that all ICM cells acquire a PrE fate when
cultured in the presence of saturated levels of FGF4, and they
proposed that the local concentration of FGF4 in the inner cells is
important for the establishment of its salt-and-pepper distribution at
the blastocyst stage (Yamanaka et al., 2010). At E3.0-3.25, DP inner
cells exist as a common precursor pool and have the potential to
commit to either fate asynchronously (Saiz et al., 2016). Activity of
the Fgf4-Fgfr-ERK pathway regulates the balance of EPI and PrE
differentiation from common precursors. We demonstrated that
Fgf4 expression is induced in a subset of Fgf4-high inner cells of
Klf5 KO embryos at E3.0-3.25. At that time, the number of DP cells
was reduced in Klf5 KO embryos. Furthermore, the skewed cell fate
of Klf5 KO embryos was markedly reversed by inhibitors of MEK
and Fgfr. These results demonstrated that Klf5 is involved in the
segregation of the EPI and PrE lineages by suppressing precocious
activation of the Fgf4-Fgfr-Fgfr-ERK pathway. Further examination
of the mechanisms involved in the transcription of Klf5 and the
transcriptional activity of Klf5 protein could reveal how the bimodal
expression of Fgf4 is generated.
Given an elevation in Gata6 protein and Sox17mRNA expression
in Klf5 KO embryos at E3.0 or E3.25 (Fig. 1B, Fig. 3B, Fig. 4D),
this might suggest a cell-autonomous role for Klf5 in the PrE
lineage. However, the mRNA expression level of Sox17 at E3.0 was
much lower than that of other transcription factors such as Nanog,
Sox2 and Gata6 (Sox17/Nanog ratio=5.6×10−6, Sox17/
Sox2=5.28×10−5, Sox17/Gata6=0.00125), suggesting that Sox17
mRNA expression is very low. Furthermore, we detected no Sox17
protein expression (Fig. S3A). This is consistent with previous
reports that Sox17 is activated between the 32- and 64-cell stages in
mouse embryos (Artus et al., 2011; Morris et al., 2010; Niakan
et al., 2010). Thus, the elevation in Sox17mRNA expression in Klf5
KO ICM is still too low to cause PrE differentiation. The Gata6
protein expression level also showed a slight increase (29%) at
E3.25 (Fig. 1B), but the mRNA expression level of Gata6 was not
changed significantly between WT and Klf5 KO embryos at E3.0
(Fig. S5B) and E3.25 (Fig. 4D), indicating that Gata6 is not
regulated by Klf5 at the transcriptional level at ∼E3.0-3.25. Taken
together, these data suggest that Fgf4 regulates the induction of PrE
differentiation, rather than there being a Sox17- or Gata6-mediated
cell-autonomous mechanism.
Previous studies have demonstrated that Klf5 regulates lineage
specification in TE and ICM (Ema et al., 2008; Lin et al., 2010).
Fig. 4. Klf5 is required to suppress Fgf4 in a subset of inner cells at E3.0-
3.25. (A-C) Single-cell RT-qPCR analysis of inner cells from WT, Klf5 KO and
Klf5 OE embryos at E3.25. cDNAs extracted from 84 cells from WT embryos
(n=14), 54 cells fromKlf5KO embryos (n=7) and 53 cells fromKlf5OEembryos
(n=8) were synthesised using theSC3-seqmethod. (A) TheΔCt values from the
average Ct value of β-actin are shown as heat maps and are used for clustering.
The genotype of each sample is shown above the heat map. (B) Violin plot of
single-cell mRNA expression levels (ΔCt values from the average Ct value of
β-actin) of Fgf4 in WT, Klf5 KO and Klf5 OE inner cells at E3.25. Two cell
populations can be distinguished by Fgf4 expression level: Fgf4-high cells and
Fgf4-low/negative cells, as determined by a ΔCt value of 4.3 that marks the 25th
percentile expression levels in WT embryos. **P<0.001 (Mann–Whitney
U-test). (C) Number of Fgf4-high cells among the inner cells of WT,Klf5KO and
Klf5 OE embryos at E3.25 from single-cell RT-qPCR as shown in A. *P<0.01,
versusWT (Fisher’s exact test). (D) ΔΔCt values normalised to the averageWT
ΔCt value of Fgf4-high and Fgf4-low/negative cells in WT, Klf5 KO and Klf5OE
embryos are shown as box plots. Fgf4-high cells were determined by a ΔCt
value of 4.3 that marks the 25th percentile expression levels in WT embryos.
Sample number is indicated above each boxplot. *P<0.01, **P<0.001 (Mann–
Whitney U-test). (E) Binding peaks of Klf5 to Fgf4 in mouse ESCs. Numbers
below binding peaks indicate regions designated for ChIP primers used in F.
(F) ChIP analysis of the binding of Klf5 to Fgf4 in mouse ESCs. The promoter
region of Vegfr2, which is not regulated by Klf5, was analysed as a negative
control region. *P<0.01 (Student’s t-test). n.s., not significant.
3713
RESEARCH ARTICLE Development (2017) 144, 3706-3718 doi:10.1242/dev.150755
D
E
V
E
LO
P
M
E
N
T
While Klf5 directly regulates Sox17 (Lin et al., 2010), it is still
unclear how Klf5 regulates the balance of EPI and PrE. Our results
indicate that Klf5 is required to suppress Fgf4 in morula at E3.0, but
it is not clear whether it continues to suppress Fgf4 later in
development because Klf5 KO ESCs expressed normal levels of
Fgf4 (Fig. S5E). Fgf4 and Klf5 are expressed abundantly in such
cells and are important for their differentiation and for self-renewal,
respectively (Ema et al., 2008; Kunath et al., 2007). Cis-regulatory
regions in the Fgf4 promoter and enhancers are occupied by Klf5 in
mouse ESCs (Fig. 4F). Nevertheless, the lack ofKlf5 expression did
not significantly alter Fgf4 expression (Fig. S5E). Therefore, we
speculate that the transcriptional repression of Fgf4 by Klf5 occurs
within a brief developmental window, such that the induction of
Fgf4 does not hamper the normal segregation of EPI and PrE
lineages, and later Klf5 expression does not repress Fgf4 by the time
the mature EPI cells arise. This is consistent with the observation
that aggregation of Klf5 KO ESCs with WT tetraploid embryos
generates Klf5 KO embryos that appear normal at E8.5, indicating
that Klf5 is not required for normal development once the EPI is
established (Ema et al., 2008).
Activation of the Fgf4-Fgfr-ERK pathway destabilises a naïve
pluripotent state in mouse ESCs and promotes a primed state,
whereas a reduction in ERK activity strongly promotes naïve
pluripotency (Hamilton et al., 2013; Kunath et al., 2007; Ying et al.,
2008). However, the precise molecular mechanisms of self-renewal
promoted by ERK inhibition remain elusive. Although ERK
inhibition contributes to self-renewal in part through the
stabilisation of Klf2 and Klf4 proteins, which are subject to
proteasome-dependent degradation of ERK-phosphorylated forms
in mouse ESCs (Kim et al., 2012; Yeo et al., 2014), it is interesting
to note that Klf5 modulates the level of pERK in mouse ESCs (T.A.,
unpublished observations). ERK inhibition also facilitates the
emergence of naïve pluripotent cells in the blastocyst during murine
development (Nichols et al., 2009). It remains unclear whether there
is a specific physiological mechanism that mediates ERK inhibition
to promote pluripotency in vivo, but Klf5 could be a key genetic
Fig. 5. Inhibition of Fgfr-ERK signalling rescues the cell cycle defects of Klf5 KO blastocysts. (A) Experimental outline for assessing the role of the Fgf4-
Fgfr-MAPK pathway in Klf5 KO blastocysts. (B) Effects of inhibitors of MEK (MEKi) and Fgfr (Fgfri) in WT and Klf5 KO blastocysts. Embryos at E2.75 were
recovered and incubated in the presence or absence of MEKi (PD0325901, 1 µM) and Fgfri (SU5402, 2 µM) for 24 h, and then subjected to TUNEL assay and
immunohistochemistry. z-projected confocal microscopy transverse sections are shown. C, cell number. Scale bars: 25 µm. (C) Number of cells (left) and
percentages of TUNEL+ (apoptotic) cells (right) per embryo. Embryo numbers are shown in parentheses. (D) Bright-field and fluorescent images of WT embryos
cultured in the presence of FGF4 (1 μg/ml) from E2.75 to E3.75 and of Klf5 KO embryos at E3.75. Maximum intensity projections of confocal microscopy images
are shown. Scale bars: 20 µm. (E)WTembryos cultured in the presence of FGF4 showed a slight, but not significant, reduction in cell number (left) and increase in
the percentage of TUNEL+ cells (right). Embryo numbers are shown in parentheses. *P<0.01, **P<0.001 (Mann–Whitney U-test).
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component in this regard. Further investigation of the functions of
Klf5might allow us to understand how the symmetric expression of
Fgf4 and Fgfr2 is altered during early development.
MATERIALS AND METHODS
Generation of Klf5 KO and OE transgenic mice
Klf5lacZ/lacZmice were generated as previously described (Ema et al., 2008).
The lacZ cassette was inserted into the second exon of the Klf5 gene.
Conditional KO and OE alleles for Klf5 were generated as described in the
supplementary Materials and Methods. Primers used for the genotyping of
the conditional KO and OE alleles for Klf5 mice are described in Table S1.
Mouse embryos were recovered at noon of the day on which the vaginal plug
was discovered (considered E0.5).
Pluripotent stem cells
Mouse Klf5+/+ (WT)::Oct3/4-ireszeocinR ESCs, Klf5lacZ/lacZ (KO)::Oct3/4-
ireszeocinR ESCs and Klf5+/+ (WT)::Oct3/4-ireszeocinR::Klf5 OE ESCs
were generated as previously described (Ema et al., 2008) and were cultured
in DMEM+15% Knockout Serum Replacement (KSR; Invitrogen). Details
are provided in the supplementary Materials and Methods.
Manipulation of early embryos
Embryo manipulations were performed according to Nagy et al. (2003). For
immunosurgery followed by ESC derivation, blastocysts were incubated
with rabbit anti-mouse red blood cell antibody (Inter Cell Technologies,
A3840; 1:8) for 10 min. After the blastocysts were briefly washed twice in
M2, they were incubated with guinea pig serum (Calbiochem) for 15 min.
Fig. 6. Treatment with Fgfr or MEK inhibitors reverses the skewed lineage specification of Klf5 KO blastocysts. (A) Experimental outline to assess the
role of the Fgf4-Fgfr-ERK pathway in Klf5 KO embryos. Embryos were collected from Klf5 heterozygous intercrosses at E2.5 and cultured in the presence or
absence of MEKi (PD0325901, 1 µM) for 24 h and 48 h. (B,B′) Effects of MEKi on skewed lineage specification of Klf5 KO blastocysts at E3.5 (B) and E4.5 (B′).
Confocal microscopy transverse sections are shown. C, cell number. Scale bars: 20 µm. (C) Tukey box plots of Nanog and Gata6 protein expression levels per
embryo and the percentage of Nanog+ and Gata6+ cells per embryo. Embryo numbers are shown in parentheses. Mean and s.e.m. of three independent
experiments. A.U., arbitrary unit. *P<0.01, **P<0.001 (Mann–Whitney U-test).
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After removal of the zona pellucidae with acidic Tyrode’s solution (Sigma-
Aldrich), the cells were cultured in ESC medium for 2 weeks on a gelatine-
coated dish. For in vitro culture of early mouse embryos, embryos at the 2-
cell stage or later were incubated in KSOM (Millipore) in the presence or
absence of PD0325901 (1 µM;Wako), SU5402 (2 µM;Wako), CHIR99021
(Chiron; 3 µM; Wako), JNK inhibitor II (5 µM; Calbiochem), SB203508
(10 µM; Calbiochem) or LY924002 (10 µM; Calbiochem). To activate the
Fgf4-Fgfr-ERK pathway, recombinant human FGF4 (R&D Systems) was
added at a saturated concentration (1 μg/ml) prepared in KSOM. 1 µg/ml
heparin (Sigma) was added together with FGF4 or control. BrdU was added
(10 µM; BD Pharmigen) for 2 h, and BrdU Flow Kits (BD Pharmingen)
were used for detection.
Immunohistochemistry
Embryos were fixed in 4% paraformaldehyde (PFA) in PBS for 15 min,
permeabilised in 0.5% Triton X-100 for 15 min and incubated in blocking
reagent (PBS, 10% donkey serum, 0.1% BSA, 0.01% Tween 20) for 1 h.
Embryos were incubated at 4°C overnight with primary antibodies prepared
in blocking reagent. After the embryos were washed with PBS+0.5% Triton
X-100, they were incubated with secondary antibodies in the blocking
reagent for 3 h at 4°C. Nuclei were stained with Hoechst 33342 (10 µg/ml;
Molecular Probes). Antibodies used for the immunohistochemistry are
described in Table S2. Immunohistochemistry with anti-FGF4 antibody was
performed as described in the supplementary Materials and Methods.
Confocal microscopy analysis and image data acquisition
Embryos were mounted in drops of 30% glycerol on glass-bottom dishes.
Confocal images were acquired using a Leica TCS SP5 or SP8 camera.
Fluorescence was excited with a 405 nm UV laser for Hoechst 33342, a 638
nm laser for Cy5 or Alexa Fluor 633, a 552 nm laser for Cy3, and a 488 nm
laser for Alexa Fluor 488. Images were acquired using an HC PL APO CS2
40×/1.30 oil-immersion objective lens (Leica), with optical sections of
2-2.5 µm. A hybrid detector system (Leica) was used for the acquisition of
raw images, which were processed using Leica software or Photoshop CS6
(Adobe). Cell nuclei were counted manually using ImageJ image analysis
software (National Institutes of Health). Protein expression levels were
analysed as described (Dietrich and Hiiragi, 2007; Kang et al., 2013).
Briefly, mean fluorescence intensities inside regions of interest (for
example, nuclei) were measured, and subtracted from background signals,
which were defined as the average of the mean fluorescence intensities of
randomly chosen cytoplasmic signals, and were then normalised against the
mean fluorescence intensity in the Hoechst channel using ImageJ (Dietrich
and Hiiragi, 2007). We defined a cell as positive if it showed a higher
fluorescence signal than the background. To quantify Nanog and Gata6
protein expression levels, we measured Nanog expression in both Nanog+/
Gata6− and Nanog+/Gata6+ (DP) cells, and Gata6 expression in both
Gata6+/Nanog− and DP cells.
For the quantification of FGF4 expression in preimplantation embryos,
background signals were subtracted from mean fluorescence intensities
inside regions of interest in the cytoplasm of FGF4+ cells. Background
signals were defined as the average of the mean fluorescence intensities of
randomly chosen cytoplasmic regions in without-antibody negative
controls. FGF4 expression values were then normalised against the mean
fluorescence intensity in the Hoechst channel using ImageJ. Individual cells
were distinguished using intercellular gaps seen in differential interference
contrast (DIC) images from the same focal plane as the corresponding
confocal microscopy image.
TUNEL assay
Apoptotic cells were identified using the DeadEnd Fluorometric TUNEL
System (Promega). For counting TUNEL+ cells, individual cells were
identified using the intercellular gaps seen in DIC images merged with
images of nuclear staining and TUNEL staining. Fragmented or pyknotic
nuclei bounded by the same intercellular gap were counted as one cell.
Fig. 7. Model for the role of Klf5 in ICM lineage
specification. At E3.0, the inner cells are DP
precursors. At E3.5-3.75, the salt-and-pepper
distribution of Nanog and Gata6 is evident, and cells
are considered Nanog+ EPI and Gata6+ PrE lineage
precursor cells. At E4.0-4.25, the lineages have been
determined. Although Fgf4-ERK signalling is not
involved in the initial coexpression of Nanog and
Gata6, it regulates EPI/PrE specification by inhibiting
Nanog and maintaining Gata6 expression. In the Klf5
KO embryos, Fgf4 is overexpressed because of
derepression in the absence of Klf5, leading to PrE
lineage specification. Gata4, a late marker for PrE
lineage specification, is seen from the 64-cell stage in
Klf5 KO embryos but only in a few Klf5 OE embryos,
indicating accelerated differentiation into the PrE
lineage. At E3.5, Fgf4 is activated in EPI precursor
cells in a Nanog- and Oct3/4-dependent manner
[according to Frankenberg et al. (2011); Frum et al.
(2013); Le Bin et al. (2014); Messerschmidt and
Kemler (2010)]. Klf5 represses precocious Fgf4
transcription to suppress the Fgf4-Fgfr-ERK pathway,
thereby ensuring Nanog+ pluripotent EPI
development.
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Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed as previously described (Ito et al., 2013). Cells
were fixed with 1% formaldehyde and sonicated. The samples were
incubated with normal mouse IgG and anti-FLAG-M2 antibody. For details,
see the supplementaryMaterials andMethods. Primers used for ChIP-qPCR
are listed in Table S3.
ChIP-sequencing (ChIP-seq) data analysis
To locate Fgf4 loci occupied by Klf5 in mouse ESCs, ChIP-seq data of
Aksoy et al. (2014) were analysed as described in the supplementary
Materials and Methods.
Microarray analysis
cDNAs were synthesised from individual WT and Klf5KO embryos at E3.0
as previously described (Kurimoto et al., 2007; Nakamura et al., 2015). The
cDNAswere amplified further in a linear fashion and labelled with a Cy3- or
Cy5-conjugated nucleotide. Hybridisation procedures were performed by
TaKaRa Bio. Raw data were analysed using GeneSpring software version
13.0 (Agilent Technologies). The raw probe intensities were background
subtracted. Signal values were set to threshold level 10 and log2
transformed. Normalization was performed using a 75th percentile shift
algorithm. Further normalization using baseline to median of all samples
algorithm was performed. Transcripts were filtered with 2-fold expression
change compared with the median intensity in all samples.
Isolation of single cells for cDNA amplification
Outer cells of E3.25 embryos were removed by immunosurgery. Inner cells
were incubated in a 1:1 mixture of Accutase (Nakalai Tesque) and 0.25%
trypsin-EDTA (Invitrogen) for ∼5 min at 37°C and then dissociated into
single cells by pipetting. cDNAs were synthesised from the isolated single
cell using the single-cell mRNA 3-prime sequencing (SC3-seq) method as
previously described (Nakamura et al., 2015).
RT-qPCR analysis
First-strand cDNA was synthesised from total RNA using the QuantiTect
Reverse Transcription Kit (Qiagen). Real-time PCR was performed with
SYBR Premix Ex Taq II (TaKaRa) and analysed on a Thermal Cycler Dice
Real-Time System (TP850; TaKaRa). The amount of target RNA was
estimated using an appropriate standard curve and divided by the estimated
amount of β-actin for normalisation. Primers used for RT-qPCR are listed in
Table S3.
Statistical analysis
Statistical analyses were performed using the nonparametric Mann–
Whitney U-test or Student’s t-test. Data are expressed as the mean and s.
e. Differences were considered significant at P<0.05. Statistical analyses
were performed using Prism6 (GraphPad) for the nonparametric Mann–
WhitneyU-test and Excel (Microsoft) for Student’s t-test. Single-cell qPCR
data analysis was performed using R software with gplots (ver. 3.0.1) and
ggplot2 (ver. 2.2.1) and Excel (Microsoft).
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